Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

NCT ID: NCT01625598

Last Updated: 2014-04-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-04-30

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hypothesis is that computer detection of the severity of diabetic retinopathy including the presence of clinically significant macular edema is not inferior to the detection using a dilated eye examination by a Board-certified ophthalmologist.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The project is a multicenter, observational study to compare the accuracy of the IDX-DR computer detection system to board certified ophthalmologists performing dilated eye examination at identifying between no or mild NPDR without clinically significant diabetic macular edema from more than mild NPDR with or without CSDME. Approximately 400-600 persons with diabetes will be recruited through 5 clinical centers. The ophthalmologist who examines the patient will evaluate and record the status of the eye based on his/her clinical examination. The study subjects will then have two fundus photographs taken of each eye. The photographic images will be transferred to a central Reading Center at the University of Pennsylvania and interpreted by professional graders. The Reading Center will then transfer the images to IDx-DR, the computer detection system. IDx-LLC, the Sponsor of this study, will have no access to the images. Data from the Reading Center interpretation will be considered the "gold standard". The results of the clinical examination and IDX-DR will be compared against this gold standard as well as against each other.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Retinopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

People with diabetes

People with diabetes who are referred to an ophthalmologist for a dilated eye examination

Photography of the retina

Intervention Type PROCEDURE

Every subject will undergo photography of the retina in both eyes

Retinal photography

Intervention Type PROCEDURE

Device

Subjects will have photography of both eyes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Photography of the retina

Every subject will undergo photography of the retina in both eyes

Intervention Type PROCEDURE

Retinal photography

Device

Subjects will have photography of both eyes

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* a diagnosis of diabetes mellitus
* subject understands study and has signed informed consent
* no history of any other retinal vascular disease, glaucoma, or other disease that may affect the appearance of the retina or optic disc (refractive error and ocular surface disease are allowed);
* other than cataract surgery, no history of intraocular surgery, ocular laser treatments for any retinal disease, or ocular injections for diabetic macular edema or proliferative disease
* no media opacity precluding good retinal photography
* age 18 or older

Exclusion Criteria

* no diagnosis of diabetes mellitus
* potential subject cannot understand study or informed consent
* a history of retinal vascular disease other than due to diabetic retinopathy, glaucoma, or other disease that may affect the appearance of the retina or optic disc
* previous intraocular surgery other than cataract; previous laser to the retina; or previous intraocular injections for the treatment of diabetic retinopathy
* a media opacity in either eye that is severe enough to preclude good retinal photography
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pennsylvania

OTHER

Sponsor Role collaborator

University of Iowa

OTHER

Sponsor Role collaborator

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role collaborator

Iowa Eye Center, Cedar Rapids IA

UNKNOWN

Sponsor Role collaborator

VitreoRetinal Surgery, PA

OTHER

Sponsor Role collaborator

Retina Consultants Houston

OTHER

Sponsor Role collaborator

Barnet Dulaney Perkins Eye Centers

NETWORK

Sponsor Role collaborator

Digital Diagnostics, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jordan Graff, MD

Role: PRINCIPAL_INVESTIGATOR

Barnet Dulaney Perkins Eye Center - Phoenix & Mesa AZ

Brian Privett, MD

Role: PRINCIPAL_INVESTIGATOR

Iowa Eye Center, Cedar Rapids IA

Timothy Johnson, MD

Role: PRINCIPAL_INVESTIGATOR

University of Iowa, Iowa City IA

James Major, MD

Role: PRINCIPAL_INVESTIGATOR

Retina Consultants of Houston - Houston TX (2 locations)

Judianne Kellaway, MD

Role: PRINCIPAL_INVESTIGATOR

Robert Cizik Eye Center - University of Texas Houston

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Barnet Dulaney Perkins Eye Center

Mesa, Arizona, United States

Site Status

Barnet Dulaney Perkins Eye Center

Phoenix, Arizona, United States

Site Status

Iowa Eye Center

Cedar Rapids, Iowa, United States

Site Status

University of Iowa Department of Ophthalmology and Visual Sciences

Iowa City, Iowa, United States

Site Status

Retina Consultants of Houston

Houston, Texas, United States

Site Status

Robert Cizik Eye Clinic - University of Texas Houston

Houston, Texas, United States

Site Status

Retina Consultants of Houston

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.